I recently had a chance to attend the Texas Healthcare & Bioscience Institute’s 2017 Fall Policy Summit. The event, held in Austin, brought together a number of stakeholders in the biotechnology sector. There are a number of pharmaceutical and medical device companies emerging from efforts in Texas. It is exciting to see the advancement of new therapies and devices. Focusing on the promise of innovation in science remains a theme in this sector. I look forward to working with these stakeholders to reach compliance with the Federal Food, Drug & Cosmetic Act, marketing their products and improving consumer health.